Only 38 cases of SEGA have been described in patients without other clinical features of TSC, but in 7 out of 9 cases in which molecular analysis was performed, a mutation of TSC-1 or TSC-2 was still detected in tumor tissue [2]. This evidence concerns the gene TSC2 and tuberous sclerosis.